New and Media

Media Release
March 18, 2021
Nationwide Children’s Hospital Affiliate Andelyn Biosciences Receives Significant Investment and Enters Into Strategic Partnership with Pall Corporation and Cytiva
Blog
November 11, 2021
Andelyn Biosciences has established a unique network of industry experts across the entire development and commercialization spectrum. In addition to...
Blog
October 22, 2021
Andelyn Biosciences is building the best cell and gene therapy team in spite of a talent shortage and competitive talent...
Blog
September 23, 2021
The analytical requirements for viral vectors used to deliver gene therapies are complex and constantly evolving. The keys to success,...
Blog
September 16, 2021
The number of gene therapy candidates in development is growing rapidly, with many advancing toward late-stage trials. The majority of...
Blog
August 23, 2021
Abstract: Andelyn Biosciences, a full-spectrum gene therapy CDMO organization that supports clients from preclinical studies through phase III trials, originally...
Blog
June 20, 2021
Adeno-associated viruses (AAV) are small viruses that can infect humans and other primate species. The particularity about AAV is that...
Blog
February 15, 2021
“What’s in a name?” the saying goes. In this case, much more than meets the eye. Andelyn Biosciences is much...
Blog
November 15, 2020
Viral vectors are an essential part of gene therapy treatments. They are essential for delivering corrected genetic information to faulty...
Blog
September 15, 2020
Gene therapy has revolutionized medicine since the early 1990s and is one of the most promising fields in medicine. In...
Blog
July 20, 2020
Current Good Manufacturing Processes (cGMP) are outlined by the FDA, which defines them as the “minimum requirements for the methods,...